NCT05634148View on ClinicalTrials.gov

Dexmedetomidine in Reducing Incidence of Emergence Agitation After Nasal Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 22, 2022

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Postoperative Delirium
Interventions
DRUG

Dexmedetomidine

Intravenous dexmedetomidine will be administered 45 minutes before extubation in intervention group

Trial Locations (1)

Unknown

Security Forces Hospital, Riyadh

All Listed Sponsors
lead

Security Forces Hospital

OTHER